RxDoctor Payments DataLook up a doctor →

Jay Applebaum, MD

Procedural Dermatology · Tustin, CANPI 1740214618

Payments from drug & device makers

$12,897in general payments, 2019–2025

Across 591 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Novartis$1K
  • LEO Pharma Inc.$1K
  • Sanofi$977
  • Lilly USA, LLC$887
  • plus $6K from 26 others

What the payments were for

  • Speaking & faculty fees$120%
  • Travel & lodging$20%
  • Food & beverage$12,57497%
  • Education$3102%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,897 in reported general payments places this provider in the 75th percentile of 108 procedural dermatology providers in California.

See all procedural dermatology providers in California

Medicare billing

Part B allowed, 2024
$222,728
Medicare patients
564
Services billed
4,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab11$74,620
Dupixent SyringeDupilumab21$71,686
Clobetasol Propionate52$2,735
Fluocinonide38$1,514
Triamcinolone Acetonide120$1,193
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet21$1,084
Metronidazole21$993
Doxycycline Hyclate31$949
Imiquimod24$634
Nystatin27$540
Ketoconazole32$532
Clindamycin Phosphate18$449
Hydrocortisone37$378
Pentoxifylline21$287
Doxepin Hcl14$214

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Tustin

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →